Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report

Xinglin Guo; Jianzhu Shao; Jing Jing; Mingzhong Xiao; Chongxiang Xue; Qingwei LI; Yanjiao Zhang; Chensi Yao; Xuefei Zhao; Keyu Chen; Yingying Yang; Xiuyang LI; Yusheng Bai

Return

Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report

VernacularTitle:中西医结合治疗急性淋巴细胞白血病合并新型冠状病毒感染（重型）恢复期患者1例
Author: Xinglin GUO ¹ ; Jianzhu SHAO ² ; Jing JING ³ ; Mingzhong XIAO ⁴ ; Chongxiang XUE ⁵ ; Qingwei LI ⁶ ; Yanjiao ZHANG ⁶ ; Chensi YAO ⁶ ; Xuefei ZHAO ⁶ ; Keyu CHEN ⁶ ; Yingying YANG ⁷ ; Xiuyang LI ⁶ ; Yusheng BAI ³
Author Information

1. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/ National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion， Tianjin， 300381
2. Xiditou Community Health Service Center in Beichen District，Tianjin
3. Affiliated Hospital of Xinjiang University of Traditional Chinese Medicine
4. Hubei Provincial Hospital of Traditional Chinese Medicine
5. Beijing University of Chinese Medicine
6. Guang'anmen Hospital， China Academy of Chinese Medical Sciences
7. China-Japan Friendship Hospital
Publication Type:Journal Article
Keywords: COVID-19; acute lymphoblastic leukemia; deficiency of both qi and yin; binding of phlegm and blood
From: Journal of Traditional Chinese Medicine 2023;64(23):2466-2470
CountryChina
Language:Chinese
Abstract: This paper reported a case of severe COVID-19 in the recovery stage with acute lymphoblastic leukemia treated by integrated traditional Chinese and western medicine， with the intention of shedding light on the clinical diagnosis and treatment of similar conditions. The patient， who had acute lymphoblastic leukemia， developed COVID-19 infection during the bone marrow suppression period after chemotherapy. Treatment with western medicine was mainly anti-infection， symptomatic management， and supportive care. During the recovery stage， considering the patient's chemotherapy history and disease progression， the overall syndrome was identified as deficiency of both qi and yin and binding of phlegm and blood. Based on the “state-target” combined treatment strategy， herbal prescriptions were selected and modified to address the “deficiency state”， “disease target”， and “symptom target”. In addition to western medicine， the patient was administered with Shengmai Powder （生脉散） and Compound Zhebei Granules （复方浙贝颗粒） in its modifications to boost qi， nourish yin， and reinforce healthy qi， nourish and cool the blood， ultimately achieving satisfactory therapeutic effects.